DOLUTEGRAVIR

UNII:	DKO1W9H7M1
Type:	INGREDIENT SUBSTANCE
Formula:	C₂₀H₁₉F₂N₃O₅
Preferred Substance Name:	DOLUTEGRAVIR
InChIKey:	RHWKPHLQXYSBKR-BMIGLBTASA-N
GSRS Full Record:	DKO1W9H7M1 i

1051375-16-6
(3S,7R)-N-[(2,4-difluorophenyl)methyl]-11-hydroxy-7-methyl-9,12-dioxo-4-oxa-1,8-diazatricyclo[8.4.0.03,8]tetradeca-10,13-diene-13-carboxamide
(3S,7R)-N-[(2,4-difluorophenyl)methyl]-11-hydroxy-7-methyl-9,12-dioxo-4-oxa-1,8-diazatricyclo[8.4.0.03,8]tetradeca-10,13-diene-13-carboxamide
(4R,12.ALPHA.S)-N-((2,4-DIFLUOROPHENYL)METHYL)-7-HYDROXY-4-METHYL-6,8-DIOXO-3,4,6,8,12,12.ALPHA.-HEXAHYDRO-2H-PYRIDO(1',2':4,5)PYRAZINO(2,1-.BETA.)(1,3)OXAZINE-9-CARBOXAMIDE
DOLUTEGRAVIR [MI]
DOLUTEGRAVIR [USAN]
DOLUTEGRAVIR [VANDF]
DTG
Dolutegravir
Dolutegravir [WHO-DD]
GSK 1349572
GSK-1349572
GSK1349572
GSK1349572A
S-349572
dolutegravir [INN]

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

DOLUTEGRAVIR

Synonyms and Mappings

Resources